{"id":903,"date":"2025-01-01T18:16:51","date_gmt":"2025-01-01T09:16:51","guid":{"rendered":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/?p=903"},"modified":"2025-02-07T18:21:25","modified_gmt":"2025-02-07T09:21:25","slug":"new-imported-drug-approvals-by-the-nmpa-december-2024","status":"publish","type":"post","link":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/903\/","title":{"rendered":"New Imported Drug Approvals by the NMPA - December 2024"},"content":{"rendered":"<ul>\n<li>\u25a1\u3000Beclometasone\/Formoterol for Inhalation (FOSTAIR) \u2013 marketed by Chiesi Farmaceutici S.p.A.<\/li>\n<li>\u25a1\u3000Donanemab Injection (KISUNLA) \u2013 marketed by Eli Lilly and Company<\/li>\n<li>\u25a1\u3000Dotinurad Tablets (URECE) \u2013 marketed by FUJI YAKUHIN CO., LTD.<\/li>\n<li>\u25a1\u3000Imipenem, Cilastatin and Relebactam for Injection (RECARBRIO) \u2013 marketed by MSD B.V.<\/li>\n<li>\u25a1\u3000Lenacapavir Sodium Injection and Tablets (SUNLENCA) \u2013 marketed by Gilead Sciences Ireland UC<\/li>\n<li>\u25a1\u3000Loncastuximab Tesirine For Injection (ZYNLONTA) \u2013 marketed by ADC Therapeutics SA<\/li>\n<li>\u25a1\u3000Lurbinectedin for Injection (ZEPZELCA) \u2013 marketed by PharmaMar AG<\/li>\n<li>\u25a1\u3000Mepolizumab Injection (NUCALA) \u2013 marketed by GlaxoSmithKline Trading Services Limited<\/li>\n<li>\u25a1\u3000Mosunetuzumab Injection (LUNSUMIO) \u2013 marketed by Roche Pharma (Schweiz) AG<\/li>\n<li>\u25a1\u3000Odevixibat Capsules (BYLVAY) \u2013 marketed by Ipsen Pharma<\/li>\n<li>\u25a1\u3000Olaparib Tablets (Brand: N\/A) \u2013 marketed by M\/s Natco Pharma Limited<\/li>\n<li>\u25a1\u3000Osimertinib Mesylate Tablets (TAGRISSO) \u2013 marketed by AstraZeneca AB \u2013 new indication<\/li>\n<li>\u25a1\u3000Pembrolizumab Injection (KEYTRUDA) \u2013 marketed by MSD LLC \u2013 new indication<\/li>\n<li>\u25a1\u3000Pretomanid Tablets (DOVPRELA) \u2013 marketed by Mylan Ireland Limited<\/li>\n<li>\u25a1\u3000Rilonacept for injection (ARCALYST) \u2013 marketed by Kiniksa Pharmaceuticals (UK), Ltd.<\/li>\n<li>\u25a1\u3000Safinamide Mesylate Tablets (XADAGO) \u2013 marketed by Zambon S.p.A.<\/li>\n<li>\u25a1\u3000Vamorolone Oral Suspension (AGAMREE) \u2013 marketed by Santhera Pharmaceuticals GmbH<\/li>\n<li>\u25a1\u3000Zolbetuximab for Injection (VYLOY) \u2013 marketed by Astellas Pharma Europe B.V.<\/li>\n<li>(Source: BaiPharm)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u25a1\u3000Beclometasone\/Formoterol for Inhalation (FOSTAIR) \u2013 marketed by Chiesi Farmaceutici S.p.A. \u25a1\u3000Donanemab Injection (KISUNLA) \u2013 marketed by Eli Lilly and Company \u25a1\u3000Dotinurad Tablets (URECE) \u2013 marketed by FUJI YAKUHIN CO., LTD. \u25a1\u3000Imipenem, Cilastatin and Relebactam for Injection (RECARBRIO) \u2013 marketed by MSD B.V. \u25a1\u3000Lenacapavir Sodium Injection and Tablets (SUNLENCA) \u2013 marketed by Gilead Sciences Ireland UC \u25a1\u3000Loncastuximab Tesirine For Injection (ZYNLONTA) \u2013 marketed by ADC Therapeutics SA \u25a1\u3000Lurbinectedin for Injection (ZEPZELCA) \u2013 marketed by PharmaMar AG \u25a1\u3000Mepolizumab Injection (NUCALA) \u2013 marketed by GlaxoSmithKline Trading Services Limited \u25a1\u3000Mosunetuzumab Injection (LUNSUMIO) \u2013 marketed by Roche Pharma (Schweiz) AG \u25a1\u3000Odevixibat Capsules (BYLVAY) \u2013 marketed by Ipsen Pharma \u25a1\u3000Olaparib Tablets (Brand: N\/A) \u2013 marketed by...  <a class=\"excerpt-read-more\" href=\"https:\/\/www.ssri.com\/china\/e\/medicalnews\/903\/\" title=\"Read New Imported Drug Approvals by the NMPA - December 2024\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-903","post","type-post","status-publish","format-standard","hentry","category-medicalnews"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/comments?post=903"}],"version-history":[{"count":5,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/903\/revisions"}],"predecessor-version":[{"id":908,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/903\/revisions\/908"}],"wp:attachment":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/media?parent=903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/categories?post=903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/tags?post=903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}